Abstract:Herein, we described the synthesis of some new phthalazine piperazine‐pyrazole conjugates(6a‐n) and their in vitro anticancer activity against four human cancer cell lines such as PC‐3, MCF‐7, DU‐145, and A‐549. The anticancer activity results reveals that the four compounds 6c, 6h, 6i, and 6n shown promising activity than the standard drug Erlotinib. Furthermore, the in silico studies of compounds 6c, 6h, 6i, and 6n supports the in vitro anticancer results. In addition, ADMET analyses were carried out on four potent compounds and results accordant with the in vitro anticancer and in vitro EGFR tyrosine kinase inhibition data. In this paper, we describe the synthesis of some new quinoxaline‐piperazine‐oxazole amide conjugates 6a‐n from 3‐chloroquinoxaline‐2‐carbonitrile using well‐known reaction sequences. The synthesized compounds were characterized by 1H NMR,13C NMR, and mass spectral analysis. The compounds were tested for their in vitro antiproliferative activity toward four different cancer cell lines such as PC‐3, MCF‐7, DU‐145, and A‐549 by MTT method. The compounds, 6c, 6h, 6i, and 6n were found to be more potent than the standard Erlotinib. In vitro tyrosine kinase EGFR inhibition studies using four potent compounds revealed that 6n has double inhibiting tendency with value IC50 of 0.22 μM and 6h with value of IC50 0.27 μM compared to reference compound. Molecular docking studies of active compounds, 6c, 6h, 6i, and 6n on EGFR receptor suggested that all the compounds have more binding energies than that of Erlotinib. Furthermore, the in silico pharmacokinetic profile was accomplished for the active compounds, 6c, 6h, 6i, and 6n using SWISS/ADME and pk CSM, whereas compounds, 6h, 6i, and 6c followed Lipinski rule, Veber rule, Egan rule and Muegge rule. The remaining compound 6n did not follow Lipinski rule, Ghose rule because one common violation, that is, because of high molecular weight (MW > 350).

Facile synthesis and biological evaluation of tryptamine-piperazine-2,5-dione conjugates as anticancer agents

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Synthesis and biological evaluation of novel artemisone–piperazine–tetronamide hybrids

Design, Synthesis and Preliminary Biological Evaluation of 5,8-Dihydropteridine-6,7-diones That Induce Apoptosis and Suppress Cell Migration

Design, synthesis, and evaluation of benzodioxolane compounds for antitumor activity

Design, synthesis and biological evaluation of rhein–piperazine–furanone hybrids as potential anticancer agents

New quinoxaline‐piperazine‐oxazole conjugates: Synthesis, in vitro anticancer, in silico ADMET, and molecular docking studies

Design, Synthesis and Anticancer evaluation of Imamine-1,3,5-triazine derivatives

Synthesis and Cytotoxicity Screening of Piperazine-1-carbodithioate Derivatives of 2-Substituted Quinazolin-4(3H)-ones.

Design, synthesis and anti-tumor activity studies of novel pyrido[3, 4-d] pyrimidine derivatives

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Synthesis of Oleanolic Acid-Dithiocarbamate Conjugates and Evaluation of Their Broad-Spectrum Antitumor Activities

Design, Synthesis And Biological Evaluation Of Of Novel Anticancer Agent Tert-Butyl 1-Phenyl-3,4-Dihydro-1h-Pyrido[3,4-B]Indole-2(9h)-Carboxylate

Synthesis and Biological Evaluation of Piperidyl Benzimidazole Carboxamide Derivatives As Potent PARP-1 Inhibitors and Antitumor Agents

Design, Synthesis and In‐Silico Studies of Piperidine‐Dihydropyridine Hybrids as Anticancer Agents

One-pot two-step catalytic synthesis of 6-amino-2-pyridone-3,5-dicarbonitriles enabling anti-cancer bioactivity

Design, Synthesis and Anticancer Activity of a New Series of N-aryl-N′-[4-(pyridin-2-ylmethoxy)benzyl]urea Derivatives

Design, Synthesis and Biological Evaluation of Novel 7-Amino-[1,2,4]triazolo[4,3-f]pteridinone, and 7-Aminotetrazolo[1,5-f]pteridinone Derivative As Potent Antitumor Agents

Synthesis and Biological Evaluation of Novel Pyrazoline Derivatives Containing Indole Skeleton As Anti-Cancer Agents Targeting Topoisomerase II.

Design, Synthesis, Anticancer Evaluation and In Silico Studies of Imidazole Pyrazine Compounds

Design, Synthesis, Antitumor Activity Evaluation, and Molecular Dynamics Simulation of Some 2-Aminopyrazine Derivatives